Bioengineered Protein Drugs Market with COVID-19 Impact Analysis, by Drugs Type (Peptide hormones, Recombinant protein drugs, Therapeutic enzymes, Vaccines, Cytokines, Monoclonal antibodies, Peptide antibiotics, Replacement proteins, Others), by Diseases (Cancer, Diabetes, Blood disorders, Skin diseases, Neurodegenerative diseases, Heart diseases, Infectious diseases, Respiratory diseases, Others), by Technology (Bioreactors and microbial cell fermentation, Fractionation, Genetically modified organisms, Genetic engineering, Pharming, Others), By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Bioengineered Protein Drugs Market size was valued at USD 3,54,100.22 Million in 2022, expanding at a CAGR of 8.01% from 2023 to 2030.
Bioengineered protein therapeutics are medically useful compounds produced by genetic engineering techniques, frequently employing live organisms like mammalian cells or bacteria to manufacture proteins with particular medicinal properties. The functions of proteins that occur naturally in the body are mimicked or enhanced by these medications, which are used to treat a variety of illnesses and ailments including diabetes, cancer, and autoimmune diseases. Due to their ability to precisely target certain biological processes, reduce side effects, and provide hopeful options for enhancing patient health and well-being, they are an essential class of medications.
Bioengineered Protein Drugs Market- Market Dynamics
- Increasing prevalence of complex and challenging-to-treat diseases to propel market demand
The demand for medications made from bioengineered proteins is significantly fueled by the rising frequency of complicated and difficult-to-treat disorders. Treatments for illnesses including autoimmune disorders, cancer, and uncommon genetic diseases frequently need to be highly focused and individualized. treatment enzymes and monoclonal antibodies are two examples of bioengineered protein therapeutics that provide precise and potent treatment solutions. Furthermore, improvements in biotechnology and genetic engineering have made it feasible to produce these medications more effectively, lowering production costs and increasing accessibility. As a result, there is an increasing need for bioengineered protein therapeutics due to their potential to enhance patient results and standard of life, as well as the increased understanding of disease causes and the possibility for customized therapy.
Bioengineered Protein Drugs Market- Key Insights
- As per the analysis shared by our research analyst, the global Bioengineered Protein Drugs market is estimated to grow annually at a CAGR of around 8.01% over the forecast period (2023-2030)
- The Bioengineered Protein Drugs industry is projected to grow at a significant rate due to the increasing prevalence of complex and challenging-to-treat diseases
- Based on drug type segmentation, Therapeutic enzymes was predicted to show maximum market share in the year 2022
- Based on disease segmentation, Diabetes was the leading type in 2022
- Based on technology segmentation, Pharming was the leading type in 2022
- On the basis of region, North America was the leading revenue generator in 2022
Bioengineered Protein Drugs Market- Segmentation Analysis:
The Global Bioengineered Protein Drugs Market is segmented on the basis of Drug Type, Disease, Technology, and Region.
The market is divided into categories based on Drug Type: Peptide hormones, Recombinant protein drugs, Therapeutic enzymes, Vaccines, Cytokines, Monoclonal antibodies, Peptide antibiotics, Replacement proteins, and Others. Due to their adaptability in treating a variety of ailments and their potential for use in personalized medicine, therapeutic enzymes are projected to dominate the bioengineered protein medication industry.
The market is divided into categories based on Disease: Cancer, Diabetes, Blood disorders, Skin diseases, Neurodegenerative diseases, Heart diseases, Infectious diseases, Respiratory diseases, Others. Due to the high incidence of the condition, rising demand for insulin and associated treatments, and continuous research for novel therapies, diabetes is predicted to dominate the market for bioengineered protein therapeutics.
Bioengineered Protein Drugs Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. Due to the significant technical breakthroughs and intensive R&D conducted for the production of bioengineered protein therapeutics, North America is projected to dominate the market.
Bioengineered Protein Drugs Market- Competitive Landscape:
Companies sell their products through a variety of channels, including corporate websites, e-commerce websites, retailers, distributors, and end consumers. Products makers compete on a variety of aspects, including product costs, performance, product making, Distribution channel, reputation, and availability. Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new product launches, distribution network development, R&D spending, and mergers and acquisitions. For instance, in April 2022, Satellite Bio introduces a fresh method for creating tissues using bioengineering. This business has expertise in regenerative medicine, synthetic biology, cell biology, cell therapy, and tissue engineering.
Recent Developments:
- In January 2022, a new biotechnology business called Altos Labs was founded with the goal of deciphering the intricate biology behind the programming of cellular renewal.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL BIOENGINEERED PROTEIN DRUGS MARKET KEY PLAYERS
- Vertex Pharmaceuticals
- Sanofi
- Regeneron Pharmaceuticals
- Pfizer
- Novo Nordisk
- Merck & Co.
- Johnson & Johnson (Janssen Pharmaceuticals)
- Gilead Sciences
- Genentech (Roche)
- Eli Lilly and Company
- Bristol-Myers Squibb
- Biogen
- AstraZeneca
- Amgen
- AbbVie
GLOBAL BIOENGINEERED PROTEIN DRUGS MARKET, BY DRUG TYPE
- Peptide hormones
- Recombinant protein drugs
- Therapeutic enzymes
- Vaccines
- Cytokines
- Monoclonal antibodies
- Peptide antibiotics
- Replacement proteins
- Others
GLOBAL BIOENGINEERED PROTEIN DRUGS MARKET, BY DISEASES
- Cancer
- Diabetes
- Blood disorders
- Skin diseases
- Neurodegenerative diseases
- Heart diseases
- Infectious diseases
- Respiratory diseases
- Others
GLOBAL BIOENGINEERED PROTEIN DRUGS MARKET, BY TECHNOLOGY
- Bioreactors and Microbial Cell Fermentation
- Fractionation
- Genetically Modified Organisms
- Genetic Engineering
- Pharming
- Others
GLOBAL BIOENGINEERED PROTEIN DRUGS MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
Rest of MEA
TABLE OF CONTENT
1. Bioengineered Protein Drugs Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Bioengineered Protein Drugs Market Snippet by Drug Type
2.1.2. Bioengineered Protein Drugs Market Snippet by Diseases
2.1.3. Bioengineered Protein Drugs Market Snippet by Technology
2.1.4. Bioengineered Protein Drugs Market Snippet by Country
2.1.5. Bioengineered Protein Drugs Market Snippet by Region
2.2. Competitive Insights
3. Bioengineered Protein Drugs Key Market Trends
3.1. Bioengineered Protein Drugs Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Bioengineered Protein Drugs Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Bioengineered Protein Drugs Market Opportunities
3.4. Bioengineered Protein Drugs Market Future Trends
4. Bioengineered Protein Drugs Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Bioengineered Protein Drugs Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Bioengineered Protein Drugs Market Landscape
6.1. Bioengineered Protein Drugs Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Bioengineered Protein Drugs Market – By Drug Type
7.1. Overview
7.1.1. Segment Share Analysis, By Drug Type, 2022 & 2030 (%)
7.1.2. Peptide hormones
7.1.3. Recombinant protein drugs
7.1.4. Therapeutic enzymes
7.1.5. Vaccines
7.1.6. Cytokines
7.1.7. Monoclonal antibodies
7.1.8. Peptide antibiotics
7.1.9. Replacement proteins
7.1.10. Others
8. Bioengineered Protein Drugs Market – By Diseases
8.1. Overview
8.1.1. Segment Share Analysis, By Diseases, 2022 & 2030 (%)
8.1.2. Cancer
8.1.3. Diabetes
8.1.4. Blood disorders
8.1.5. Skin diseases
8.1.6. Neurodegenerative diseases
8.1.7. Heart diseases
8.1.8. Infectious diseases
8.1.9. Respiratory diseases
8.1.10. Others
9. Bioengineered Protein Drugs Market – By Technology
9.1. Overview
9.1.1. Segment Share Analysis, By Technology, 2022 & 2030 (%)
9.1.2. Bioreactors and Microbial Cell Fermentation
9.1.3. Fractionation
9.1.4. Genetically Modified Organisms
9.1.5. Genetic Engineering
9.1.6. Pharming
9.1.7. Others
10. Bioengineered Protein Drugs Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
10.2. North America
10.2.1. Overview
10.2.2. Bioengineered Protein Drugs Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.2.4. North America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.2.5. North America Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.2.6. North America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Bioengineered Protein Drugs Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.3.10.5. France Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Bioengineered Protein Drugs Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.4.7.5. India Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.4.8.5. China Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Bioengineered Protein Drugs Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Bioengineered Protein Drugs Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Bioengineered Protein Drugs Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Vertex Pharmaceuticals
11.2.2. Sanofi
11.2.3. Regeneron Pharmaceuticals
11.2.4. Pfizer
11.2.5. Novo Nordisk
11.2.6. Merck & Co.
11.2.7. Johnson & Johnson (Janssen Pharmaceuticals)
11.2.8. Gilead Sciences
11.2.9. Genentech (Roche)
11.2.10. Eli Lilly and Company
11.2.11. Bristol-Myers Squibb
11.2.12. Biogen
11.2.13. AstraZeneca
11.2.14. Amgen
11.2.15. AbbVie
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
